Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
CBAK Energy to Report fourth quarter & full year 2024 Unaudited Financial Results on Monday, March 17, 2025 2025-03-10 21:00
SunCar Wins Contract to Build Insurance Platform for Major EV Maker Leapmotor 2025-03-10 20:45
Yum China Appoints Adrian Ding as Chief Financial Officer 2025-03-10 18:30
ChipMOS REPORTS FEBRUARY 2025 REVENUE 2025-03-10 18:00
HD Hyundai Executive Vice Chairman Chung Kisun meets with Palantir CEO Alex Karp to discuss 'AI Shipyard' 2025-03-10 11:02
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR® 2025-03-10 07:16
BEST Inc. Announces Completion of Going Private Transaction 2025-03-08 08:00
Health In Tech to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 2025-03-08 05:30
APAL Unveils Hestia NTN IoT Dongle at Satellite 2025, U.S. Launch on Amazon by March 2025-03-08 00:00
GigaMedia Announces Purchase of Convertible Note of Aeolus Robotics Corporation 2025-03-07 22:00
Baidu Announces Pricing of US$2 Billion Offering of Zero Coupon Exchangeable Bonds 2025-03-07 21:57
HIGHWAY HOLDINGS APPOINTS MARCUM ASIA AS NEW AUDITOR 2025-03-07 20:00
SU Group Secures Top Multi-Purpose Sports Venue 2025-03-07 20:00
Namibox Integrates DeepSeek AI Model, Pioneering Innovation in K9 Digital Education 2025-03-07 19:00
JungKwanJang to Showcase Functional Red Ginseng Solutions at 2025 Natural Products Expo West 2025-03-07 18:03
DouYu International Holdings Limited to Report Fourth Quarter and Full Year 2024 Financial Results on March 14, 2025 2025-03-07 17:00
MINISO Group Will Report December Quarter and Full Year 2024 Financial Results on March 21, 2025 2025-03-07 16:57
Baidu Announces Proposed Offering of Exchangeable Bonds 2025-03-07 16:30
AEWIN Showcases High-Density Edge Computing Server at Embedded World 2025 2025-03-07 14:16
Akeso Announces The Publication of Its Phase III Clinical Trial Results for Ivonescimab in Head-to-Head Comparison with Pembrolizumab in The Lancet 2025-03-07 13:03
1 169 170 171 172 173 2434